Form EFFECT Anebulo Pharmaceuticals,
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | September 23, 2025 |
| Accession Number: | 0001493152-25-014238 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- In HelloNation, Dental Experts Dr. Sulakshana "Sue" Sundaresan & Dr. Min Deng Highlight Dental Emergencies & Immediate Care Steps
- Dune Oil Announces $8 Million Brokered LIFE Offering to Advance Flow Testing and Production Operations on Block M47's Existing Onshore Light Oil Discovery Located at the Centre of Turkiye's Fastest Gr
- In HelloNation, Expert Car Dealer Sarah Pesek Compares Buying New & Used Vehicles
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share